Related Experiment Videos

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice

U Rudolph1, M J Finegold, S S Rich

  • 1Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA.

Nature Genetics
|June 1, 1995
PubMed

Insights

Mice lacking the G protein subunit alpha i2 (Gαi2) developed growth retardation, colitis, and colon cancer, offering insights into human ulcerative colitis and cancer development.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Immunology

Background:

  • G proteins are crucial for cellular signaling pathways.
  • These pathways regulate vital biological processes like differentiation and development.
  • Dysregulation of G protein signaling is implicated in various diseases.

Purpose of the Study:

  • To investigate the role of the G protein subunit alpha i2 (Gαi2) in biological processes.
  • To generate and characterize Gαi2-deficient mice.
  • To explore the potential link between Gαi2 deficiency and inflammatory bowel disease or cancer.

Main Methods:

  • Homologous recombination in embryonic stem cells was used to create Gαi2-deficient mice.
  • Phenotypic analysis of the generated Gαi2-deficient mice.
  • Histopathological examination of tissues from deficient mice.

Main Results:

  • Gαi2-deficient mice exhibited growth retardation.
  • These mice developed a lethal diffuse colitis mirroring human ulcerative colitis.
  • Colon adenocarcinoma developed in Gαi2-deficient mice.
  • Profound alterations in thymocyte maturation and function were observed prior to clinical symptoms.

Conclusions:

  • Gαi2 deficiency leads to severe gastrointestinal pathology and cancer development.
  • The Gαi2-deficient mouse model offers valuable insights into ulcerative colitis pathogenesis.
  • This model can advance understanding of colitis-associated carcinogenesis.

Related Concept Videos